Elucidating the exact pharmacological mechanism of action (MOA) of naturally developing compounds might be hard. While Tarselli et al. (sixty) produced the main de novo artificial pathway to conolidine and showcased this naturally transpiring compound efficiently suppresses responses to the two chemically induced and inflammation-derived pain, the